Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 15, 2011

GILEAD SCIENCES, INC. et al v. NATCO PHARMA LIMITED et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. December 21, 2012

    Gilead Ditches Double-Patenting Claim In Tamiflu Suit

    A New Jersey federal judge ruled Friday that Gilead Sciences Inc. did not unlawfully extend a patent for its flu drug Tamiflu, squashing generics maker Natco Pharma Ltd.'s bid to invalidate the patent in an attempt to market a generic version.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login